12.11.2014 • NewsApecBayerBitterfeld

Hi-Bis Doubles Capacity for Specialty Bisphenols at Bitterfeld

Bitterfeld, Germany-based Hi-Bis, a joint venture of Japanese companies Honshu Chemical Industry (55%), Mitsui (35%) and Bayer MaterialScience (BMS, 10%), has doubled capacity for specialty bisphenols, a key component of the Apec polycarbonate copolymers, to 10,000 t/y.

The investment of around €50 million enhances the company's ability to meet strong global demand for Apec, a particularly temperature-resistant, high-performance plastic.

Hi-Bis started up its first production facility at Bitterfeld in 2004, the first Japanese investment in the eastern German state of Saxony-Anhalt. The current capacity expansion, the company said, was made necessary by "steadily rising market demand."

Rainer Rettig of BMS, head of sales for Europe and other regions, said Apec demand continues to grow well above the 5% average growth rate for the plastics market. BMS produces the plastic at Antwerp, Belgium.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences

The Start-up Platform for Chemistry & Life Sciences

The tasks range from employee protection, site security and crisis management to IT, OT and production security.

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
24.01.2025 • News

CEFIC Publishes 2024 Facts and Figures Report

CEFIC , the European Chemical Industry Council, has published its 2024 Facts & Figures report, which reinforces the need to take bold and urgent action to secure Europe’s industrial future, not only to implement the Green Deal but also to prevent further de-industrialization in Europe.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.